Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life,
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …

Progress in the treatment of progressive involuntary weight loss in patients with cancer
(cancer cachexia) remains dismally slow. Cancer cachexia and its associated clinical …

Objectives Sarcopenia is characterized by progressive and generalized loss of skeletal
muscle mass and strength. We aimed to investigate sarcopenia in patients with stage I non …

Conclusions: One third of the patients had cachexia with an association of significantly
shorter survival. These results suggest that combining HGS and MAMA seems to be a …

Purpose: Cancer-associated weight loss is associated with poor prognosis in advanced
malignancy; however, its pretreatment prevalence and survival impact are inadequately …

Objectives There is growing awareness of the relationship between sarcopenia (loss of
muscle mass and function), and outcomes in cancer, making it a potential target for future …

Purpose Anorexia is a frequently observed symptom in patients with cancer and is
associated with limited food intake and decreased quality of life. Diagnostic instruments …

Background Approximately 50% of cancer patients eventually develop a syndrome of
prolonged weight loss (cachexia), which may contribute to primary resistance to immune …

Background Progressive loss of muscle mass is a major characteristic of cancer cachexia.
Consensus definitions for cachexia provide different options to measure muscle mass. This …

Introduction Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC)
patients. Cachexia index (CXI) was developed to assess the degree of cachexia in these …